In addition, as SPP1 is known to be a direct target gene of ERRα, and has been shown to be overexpressed in breast cancer cells and functionally contribute to cancer progression [48,49], our finding that the cholesterol-induced increase in its expression requires ERRα in breast cancer cells is consistent with cholesterol’s adverse effects on breast cancer outcome. The gene discussed is SPP1; the disease is breast carcinoma.